Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression

Authors: Lu, Kwok-Tung1; Wu, Chang-Yen2; Yen, Hao-Han2; Peng, Jeng-Hsiung2; Wang, Chi-Ling3; Yang, Yi-Ling2

Source: Neurological Research, Volume 29, Number 4, June 2007 , pp. 404-409(6)

Publisher: Maney Publishing

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Objective: To examine the effects of administration of bumetanide, a specific NKCC1 inhibitor, on traumatic brain injury (TBI)-induced interleukin-1 (IL-1) expression.

Methods: TBI model was induced by the calibrated weight drop device (450 g in weight, 2.0 m in height) in adult rats based on procedures previously reported. One hundred and sixty Wistar rats were divided into sham-control group and experimental group for time course works of TBI. The expression of IL-1? brain edema and neuronal damage were determined in these animals after TBI.

Results: We found that both mRNA and protein of IL-1? were up-regulated in the hippocampus 3?24 hours after TBI. Animals displayed severe brain edema and neuron damage after TBI. Bumetanide (15 mg/kg), a specific Na+ ?K+ ?2Cl? cotransporter inhibitor, significantly attenuated the TBI-induced neuronal damage by IL-1? overexpression. The present study suggests that administration of bumetanide could significantly decreased TBI-induced inflammatory response and neuronal damage.

Keywords: NA+ -K+ -2CL- -COTRANSPORTER; IL-1; TRAUMATIC BRAIN INJURY

Document Type: Research Article

DOI: http://dx.doi.org/10.1179/016164107X204738

Affiliations: 1: Department of Life Science, National Taiwan Normal University, Taipei, Taiwan 2: Institute of Biotechnology, National Chia-Yi University, Chia-Yi, Taiwan 3: General Education Center, National Chia-Yi University, Chia-Yi, Taiwan

Publication date: 2007-06-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page